Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1118

1.

Metastasis: Going places with VHL.

McCarthy N.

Nat Rev Cancer. 2013 Feb;13(2):78. doi: 10.1038/nrc3450. Epub 2012 Dec 21. No abstract available.

PMID:
23258107
2.

Glioblastoma: Microvesicles as major biomarkers?

Burgess DJ.

Nat Rev Cancer. 2013 Jan;13(1):8. doi: 10.1038/nrc3424. Epub 2012 Dec 13. No abstract available.

PMID:
23235913
3.

Protein arginine methyltransferases and cancer.

Yang Y, Bedford MT.

Nat Rev Cancer. 2013 Jan;13(1):37-50. doi: 10.1038/nrc3409. Epub 2012 Dec 13. Review.

PMID:
23235912
4.

Ceramide-orchestrated signalling in cancer cells.

Morad SA, Cabot MC.

Nat Rev Cancer. 2013 Jan;13(1):51-65. doi: 10.1038/nrc3398. Epub 2012 Dec 13. Review.

PMID:
23235911
5.

Colorectal cancer: A powerful model.

Seton-Rogers S.

Nat Rev Cancer. 2013 Jan;13(1):8-9. doi: 10.1038/nrc3427. Epub 2012 Dec 13. No abstract available.

PMID:
23235910
6.

Angiogenesis: A happy medium?

Burgess DJ.

Nat Rev Cancer. 2013 Jan;13(1):4-5. doi: 10.1038/nrc3426. Epub 2012 Dec 13. No abstract available.

PMID:
23235909
7.

Drug resistance: Time for mediation?

McCarthy N.

Nat Rev Cancer. 2013 Jan;13(1):6-7. doi: 10.1038/nrc3423. Epub 2012 Dec 6. No abstract available.

PMID:
23222482
8.

Identifying people at a high risk of developing pancreatic cancer.

Klein AP.

Nat Rev Cancer. 2013 Jan;13(1):66-74. doi: 10.1038/nrc3420. Epub 2012 Dec 6. Review.

9.

Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Deblois G, Giguère V.

Nat Rev Cancer. 2013 Jan;13(1):27-36. doi: 10.1038/nrc3396. Epub 2012 Nov 29. Review.

PMID:
23192231
10.

Signalling: YAP, PTEN and miR-29 size each other up.

McCarthy N.

Nat Rev Cancer. 2013 Jan;13(1):4-5. doi: 10.1038/nrc3422. Epub 2012 Nov 29. No abstract available.

PMID:
23192230
11.

Signalling: Double trouble.

Seton-Rogers S.

Nat Rev Cancer. 2013 Jan;13(1):6-7. doi: 10.1038/nrc3421. Epub 2012 Nov 29. No abstract available.

PMID:
23192229
12.

Human tumour viruses and the deregulation of cell polarity in cancer.

Banks L, Pim D, Thomas M.

Nat Rev Cancer. 2012 Dec;12(12):877-86. doi: 10.1038/nrc3400. Review.

PMID:
23175122
13.

The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes.

Raza A, Galili N.

Nat Rev Cancer. 2012 Dec;12(12):849-59. doi: 10.1038/nrc3321. Review.

PMID:
23175121
14.

Medulloblastomics: the end of the beginning.

Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ, Pomeroy SL, Korshunov A, Lichter P, Taylor MD, Pfister SM.

Nat Rev Cancer. 2012 Dec;12(12):818-34. doi: 10.1038/nrc3410. Review.

15.

DNA repair dysregulation from cancer driver to therapeutic target.

Curtin NJ.

Nat Rev Cancer. 2012 Dec;12(12):801-17. doi: 10.1038/nrc3399. Review.

PMID:
23175119
16.

MicroRNAs: Editing changes the meaning.

Seton-Rogers S.

Nat Rev Cancer. 2012 Dec;12(12):797. doi: 10.1038/nrc3413. No abstract available.

PMID:
23175118
17.

Tumour immunology: Context is key for TSLP.

Burgess DJ.

Nat Rev Cancer. 2012 Dec;12(12):796. doi: 10.1038/nrc3405. No abstract available.

PMID:
23175117
18.

Signalling: New roles for TLR2.

Alderton GK.

Nat Rev Cancer. 2012 Dec;12(12):796. doi: 10.1038/nrc3407. No abstract available.

PMID:
23175116
19.

Metastasis: Elf represses snail.

McCarthy N.

Nat Rev Cancer. 2012 Dec;12(12):795. doi: 10.1038/nrc3406. No abstract available.

PMID:
23175114
20.

Glioma: Tumour cells in reverse.

Seton-Rogers S.

Nat Rev Cancer. 2012 Dec;12(12):794. doi: 10.1038/nrc3404. No abstract available.

PMID:
23175112

Supplemental Content

Loading ...
Support Center